extrusion-based bioprinting is one of the most popular methodologies presently used due to its compatibility with various bioinks and ease of operation. [8] A typical extrusion bioprinter is composed of three units: a reservoir (e.g., syringe) that contains the bioink, a printhead through which the bioink is ejected from the reservoir, and a receiving stage where the deposited bioink is collected. [9] The printhead, the stage, or both, may be motorized to achieve elaborate control of bioprinting based on precisely designed patterns. Nevertheless, most of the current modalities are limited to the use of a single bioink during each deposition process, rendering it difficult to achieve bioprinting of sophisticated compositional structures. Several techniques have recently been advanced to overcome this limitation in an effort to improve the capacity of bioprinters to extrude more than a single bioink. For example, a simple mixing device was fixed onto the printhead for printing of two materials. [10] [11] [12] In addition, multimaterial bioprinting was realized by incorporating multiple separate printheads on a bioprinter, where mechanical co-registration of the printheads achieved the deposition of selected inks at desired locations. [13] [14] [15] [16] Despite their potential in scaling up to a larger number of materials, the deposition speed of this technique would inevitably be reduced as more nozzles are added, since fast switching among different channels and simultaneous injection of bioinks can hardly be achieved.
Here, we report a multimaterial extrusion bioprinting platform that is capable of extruding multiple coded bioinks in a continuous manner with fast and smooth switching among different reservoirs for rapid fabrication of complex (tissue) constructs. This paper provides a proof-of-concept demonstration by mounting a single printhead consisting of a bundle of seven equal-sized capillaries, each connected to a unique bioink reservoir that could be individually actuated by digitally controlled pneumatic pressure. The ejection process, when synergized with the movement of the motorized stage, allows for rapid deposition of 2D patterns and 3D architectures composed of multiple desired bioinks in a spatially defined manner, at a speed an order of magnitude faster than most existing nozzlebased bioprinting modalities. We further demonstrated the capability of our rapid continuous multimaterial bioprinter to generate miniaturized cell-laden constructs containing several types of cells, as well as its potential to fabricate gradient structures, and prototype multicomponent bioelectronics, using a broad range of bioinks from shear-thinning to conductive biomaterials. The proposed technology is likely to advance the field of extrusion bioprinting by offering strong capacity in printing speed and continuity, which is compatible with a wide variety of bioinks. Most of all, our 3D bioprinting platform may be conveniently extended to a large numbers of bioinks necessary for engineering highly complex functional biomaterials, tissues, and devices in the future.
Unlike conventional multinozzle bioprinters, which typically require mechanical switching among the physically separated nozzles to deposit multiple bioinks, our bioprinter is able to continuously eject different types of bioinks in both individual and simultaneous modes. The bioprinter consists of a Cartesian robotic stage and an array of bioink reservoirs routed to a single printhead containing seven bundled channels with equal sizes ( Figure 1A -D and Figure S1 and S2, Supporting Information). The dispensers are pneumatically driven and fed by compressed gas through valves ( Figure 1C ). Digital tuning of the extrusion is achieved using a program integrated with the bioprinter to individually (or simultaneously) switch on/off desired valve(s) and command the dispensing patterns ( Figure 1B,C) . The controllers for both the valves and the motorized stage are programmed to synchronize the actuation of the valves and the movement of the stage. The adjustment of the pneumatic pressure and valve gating duration allows the dispersion of various bioinks with different viscosities. As such, this bioprinter can print up to seven materials and rapidly switch among materials from different channels, without needing to physically change the nozzles.
Here shear-thinning bioinks formulated by a suspension of synthetic nanosilicates in water were employed for bioprinting. [17, 18] Detailed investigations of the rheological properties and the printing performance of the silicate bioinks can be found in Figure S3 -S6 in the Supporting Information. It should be noted that the 5% nanosilicate bioink was chosen as the optimal formulation that possessed proper shear-thinning properties, and was thus used to bioprint various 3D constructs. As an example, we programed the bioprinter to deposit bioinks dyed in seven different colors with increasing numbers of colors after each switch ( Figure 1E ,F and Movie S1 in the Supporting Information). The bioprinting process was continuous, and the printed microfibrous structure maintained its threedimensionality consisting of an array of spatially well-defined bioinks ( Figure 1G ). The seven bioinks could also be individually deposited via a continuous printing process (Movie S2, Supporting Information), where no noticeable switching delays were observed between adjacent materials ( Figure S7 , Supporting Information).
We next printed a series of microfibrous 2D patterns to demonstrate the capability of our bioprinter for continuous extrusion of multiple materials in well-defined manners. Each of the seven bioinks could be continuously printed in equivalent lengths along the direction of the individual microfibers, with equal or incremental spacing between the adjacent lines ( Figure S8A ,B, Supporting Information). Alternatively, the spacing between the adjacent microfibers could be maintained constant while continuous segments within individual lines were printed with decreasing lengths ( Figure S8C , Supporting Information), or both parameters might be altered simultaneously during the bioprinting process ( Figure S8D , Supporting Information). We further printed an array of microfibers composed of increments of one to seven materials along the direction of individual lines ( Figure S8E , Supporting Information). Printing of these various patterns demonstrated the capability of our platform to continuously deposit any desired type and number of bioinks on demand. The different materials could also be printed in perpendicular directions, to achieve hierarchical architecture while still maintaining a clear separation of the deposited bioinks ( Figure S8F -J, Supporting Information). The printed multimaterial microfibers could be designed to fuse into a single piece of structure when the spacing between the microfibers was reduced to match their width (Movie S3, Supporting Information). The printed microfibers joined each other and formed a cohesive piece of monolayer slab containing seven distinct but continuous segments along the direction of microfiber deposition. This ability to create fused larger-scale constructs allowed us to print more sophisticated patterns composed of multiple bioinks, which has hardly been possible using existing multiprinthead systems. [13] Our continuous multimaterial bioprinter has shown unparalleled power in overcoming this inability by depositing multiple types of materials in precisely programmed arrangements at much improved fabrication speed.
It is estimated that our continuous multimaterial bioprinter features much faster fabrication speed than most existing multinozzle systems. For a typical multinozzle printer, the switch COMMUNICATION time between nozzles averages 4-20 s. [14, 16] In comparison, our continuous bioprinting platform requires nearly no gap in such switching processes. In analyzing our fabrication procedure where we printed 15 lines each composed of seven bioinks for two layers (and thus 180 switches in total, Movie S3, Supporting Information), while our continuous bioprinter spent only 256 s for the entire printing process (at a speed of 400 mm min −1 ), a conventional multinozzle printer will consume an additional time of 720-3600 s simply devoted to physical nozzle switching and results in a total printing time of 976-3856 s, if the patterns are deposited in the same manner. Therefore, our continuous multimaterial bioprinter could achieve a speed up to 15 times faster than those of the existing nozzle-based platforms. Although the numbers in this comparison is not completely accurate due to the different materials used in the literature and in our case, it is still indicative of the potential superior capacity of our multimaterial bioprinter to deposit several bioinks than existing multinozzle platforms. The advantage of our continuous multimaterial extrusion printing system in terms of the biofabrication speed would become much more pronounced as the number of materials and the complexity of the printouts are increased. These unique features of our bioprinter have significantly promoted the current level of automation and speed among existing nozzle-based bioprinting techniques. [11, 14, 19] It should be noted that, the present system is readily expandable to as many bioinks as needed by simply increasing the number of pneumatically driven valves and reservoirs, thus affording us the possibility to rapidly generate complex constructs while simplifying instrumentation.
We next demonstrated the capability of our continuous multimaterial bioprinter to produce complex 3D constructs. 
COMMUNICATION
Simple cubes composed of 2 and 3 bioinks (Figure 2A,B) and ring-shaped blocks containing 2, 3, and 4 bioinks were readily printed ( Figure 2C-E) . Constructs containing all seven bioinks could also be fabricated in different shapes, such as a pyramid ( Figure 2F ), a three-layer stripe ( Figure 2G) , and a ten-layer stripe ( Figure 2H ). We further designed sophisticated 3D patterns and printed a set of structures resembling human organs, including brain, lung, heart, liver, kidneys, pancreas, gastrointestinal system, and bladder. Each organ-like structure contained four to seven bioinks, according to the requirements of local structures, and each was individually printed ( Figure 2I and Movie S4-S7, Supporting Information). Only one to three layers of the bioinks were deposited in these examples due to the significant amount of time required for printing these structures of relatively large scales. The bioprinting processes were rapid, and the transition among different bioinks was smooth. The printed organ-like constructs were stable, and the demarcation among adjacent materials was clear ( Figure 2J -N, and Figure S9 , Supporting Information). Our multimaterial bioprinter was also compatible with the embedded bioprinting technique. [7] Using a modified printhead with extended length, we were able to directly generate free-form shape of polyethylene glycol-diacrylate (PEGDA)/alginate coils in a Pluronic hydrogel followed by photo-crosslinking and retrieval after liquefying the supporting matrix ( Figure 2O) . Similarly, freeform alginate shapes composed of multiple bioinks, such as a dual-layer hollow tube ( Figure 2P ) and a DNA double helix-like structure ( Figure 2Q ), could be obtained with our continuous multimaterial bioprinter.
The developed rapid continuous multimaterial bioprinter should be able to generate hierarchical structures and patterns suitable for various applications in biomedicine. We sub sequently demonstrated the capability of the bioprinter in engineering complex cell-laden organs and depositing prototype bio electronic circuits. While these demonstrations are preliminary with limited resolution and functional assays, we primarily aimed to validate the concept of our continuous multimaterial extrusion bioprinting in the current work. 
Among the various photo-crosslinkable hydrogels available, gelatin methacryloyl (GelMA) has been frequently used as a bioink due to its intrinsic cell adhesion moieties that promote cell spreading and functionality. [20] Here, we adopted a mixture of GelMA and alginate as the bioink, [10] where the alginate component was used to increase the viscosity to achieve a range of bioprinting conditions. The cell-laden bioinks were photo-crosslinked to fix their structures immediately after printing. [10] Detailed investigations of the rheological properties and the printing performance of the GelMA/alginate bioinks can be found in the Supporting Information ( Figures S10-S12) . We first took advantage of the multibioink printing to design a range of different patterns including a heartlike structure (Figure 3A-E) , a kidney-like structure ( Figure S13A -F, Supporting Information), and stripes with different width ( Figure S13G -K, Supporting Information). It was clear that multiple bioinks laden with cells pre-labeled with cell trackers were effectively deposited using our continuous multimaterial bioprinter. The printed structure possessed explicitly separated borders among different cell-laden bioinks ( Figure 3B -E, and Figure S13B -F, H-K, Supporting Information). The resolution was determined to be ≈100-200 µm, as indicated from the printed stripe patterns with a range of widths ( Figure S13H-K, Supporting Information) .
We further printed a pattern of endothelialized tissue, where four sectors of bioinks laden with human dermal fibroblasts (HDFs), HepG2 human hepatocellular cells, human mesenchymal stem cells (hMSCs), and no cells, respectively, were deposited at the base, followed by integration of a pattern on top that resembled the vasculature encapsulating human umbilical vein endothelial cells (HUVECs, Figure 3F ). The fluorescence images obtained from different locations clearly revealed successful bioprinting of the desired (cell-laden) bioinks ( Figure 3G-I) , which laid down the essential basis for future fabrication of complex tissues containing hierarchical assembly of multiple cell types. The cell viability assays, determined immediately and at 1 and 7 d post-bioprinting ( Figure 3J and Figure S14A -T, Supporting Information), indicated that all cell types maintained sufficient viability under the UV crosslinking conditions adopted. Comparison with the cells pre-bioprinting ( Figure S14A -H vs I-T, Supporting Information) further revealed that the conditions selected for extrusion did not appear to affect cell viability. The cells well spread over a course of 7 d in culture ( Figure S14U -X, Supporting Information), indicating the bioactivity provided by the GelMA component of the bioink. The printed endothelialized tissue constructs were further shown to exhibit increased cell proliferation over a period of 3 d analyzed ( Figure 3K ).
In addition, we used the multimaterial extrusion bioprinter to generate gradient structures to mimic those occurring in natural tissues, such as the bone. For example, we created a ring-like structure featuring an inward-out gradient in the concentration of hydroxyapatite (HAp) embedded in the GelMA/alginate hydrogel ( Figure 4A) . Alizarin Red staining and quantification of the staining intensities further confirmed the presence of this same type of gradient in HAp contents ( Figure 4B,C) . Importantly, the shape of the printed constructs containing bioinks with different concentrations of HAp could be arbitrarily controlled to form any desired localized gradients as well as continuous or discrete patterns, as illustrated by our capability to print a bone-shaped hydrogel block ( Figure 4D ). The Alizarin Red staining indicated that different bioinks containing a range of HAp concentrations were printed across the entire structure, where the same materials (#4 and #5, #6 and #7) printed at discrete locations showed similar staining intensity, revealing reproducible deposition of the bioinks as programmed ( Figure 4E ).
The printed constructs featuring gradients of inorganic nanoparticles also demonstrated varying bioactivities. Differential attachment and proliferation of MC3T3 preosteoblasts seeded on top of the printed structure containing a gradient of HAp, were observed after 1 and 3 d of culture ( Figure 4F,H) . The cell seeding efficiency and proliferation were promoted with increasing concentration of HAp. A similar trend in cell behaviors was observed when the preosteoblasts were seeded on printed hydrogels containing a gradient of nanosilicates based on the osteoinductive property of these nanoparticles ( Figure 4G,I ). [18] This excellent freedom in reliable and smooth switching among selected bioinks during the bioprinting process is critical in recapitulating tissue-and organ-level biomimetic properties, especially when sophisticated structures and/ or complex compositions are involved.
Significant interest in bioelectronics is also emerging in biomedicine. A wide range of applications of electronics devices is possible in various fields, including epidermal sensors, soft contact lenses, neurointerfaces, implantable medical devices, and bioactuators.
[21] Bioprinting has been increasingly recognized as an excellent technique for depositing conductive bioinks for direct fabrication of bioelectronics, given its convenience, robustness, and cost effectiveness. [22] While many strategies have been developed for printing conductive bioinks, these have been mostly limited by single-ink deposition, which precluded the possibility for the production of complex electronic circuits. Taking advantage of our multimaterial bioprinting platform, we printed a prototype continuous circuit featuring conductive alginate/DNA/carbon nanotube (CNT) bioinks with 1-6 mg mL −1 CNTs in parallel ( Figure 4J ,K, and Movie S8, Supporting Information). This conductive bioink was optimized from our previous formulation used for single-material printing. [23] The printed circuit was completed by attaching a power source (coin battery, 3V) and six miniature green LEDs, which upon connection, exhibited a clear gradient in their luminescence intensity ( Figure 4L ). The differential luminescence of the LEDs was attributed to the series of resistances (0.17-3.37 Ω mm −1 ) that the conductive bioinks produced and therefore the difference in the current generated in each parallel unit ( Figure 4M,N) . Our capability for continuously printing several types of conductive bioinks has paved a new avenue for fabricating complex bioelectronics, where future bioprinting of complex circuits composed of multiple functional electronic units is envisioned.
In summary, we have developed a continuous multimaterial extrusion bioprinting strategy capable of continuously and/or simultaneously depositing up to seven types of bioinks through the integration of a digitally tunable pneumatic single-printhead system, which was able to achieve biofabrication of multicomponent structures at a speed up to 15 times faster than existing nozzle-based modalities. While our demonstrations in the current work are preliminary with limited resolution and functional assays, we primarily aimed to introduce the concept of continuous multimaterial extrusion bioprinting. To this end, we demonstrated the capacity of this platform in bioprinting of sophisticated planar and 3D patterns. In the subsequent proof-of-concept demonstrations, we showed the ability of our bioprinter to produce complex and gradient constructs for applications in tissue engineering and bioelectronics. Notably, our platform may be readily expanded to a large number of channels desired, simply by increasing the numbers of digitally actuated pneumatic valves in the system.
We believe that further optimization in the instrumentation of the bioprinting system will make it a highly efficient modality and a leap forward in the fabrication of physiologically relevant and functional tissues/organs that match the complexity of their in vivo counterparts at clinically relevant speeds. For example, it should be noted that, in the current setup we aligned the individual channels of the printhead side by side, leading to slightly nonconcentric deposition of the multiple bioinks. Nonetheless, the printhead could be further connected to a common outlet, and this different printhead design enabling the materials to mix with different volumes/rates prior to extrusion would further achieve true gradient formation at microscale. The pressure of each channel may also be individually tuned (as to the uniform pressures across different channels in our current system) to allow for dispensing of multiple bioinks with a series of rheological properties. Further optimization of the bioprinter is currently undergoing and will be reported in future publications. We foresee the widespread use of our multimaterial extrusion bioprinting in rapid construction of biomedical devices where a multitude of different materials can be adapted.
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